Abstract:Floxuridine (FUdR, 5-fluoro-2-deoxyuridine) was widely used in patients with tumor. But the poor activity and severe side effects have been observed in the clinic, which resulted from increased degradation cleavage of FUdR to 5-FU by thymidine phosphorylase and reduced transporter-mediated entry into cells. In this study, we have synthesized a series of l-aspartic acid β-esters and l-glutamic acid γ-esters of FUdR to improve the metabolic stability of FUdR and target FUdR to cancer cells via amino acid transporter ATB0,+ which was exclusively up-regulated in some cancerous tissue. The uptake mechanism, stability, in vitro/in vivo antiproliferation action, pharmacokinetics, and tissue distribution were studied. The combined results showed the unusual 5′-β-l-Asp-FUdR possessed a better tumor inhibition rate and a better metabolic stability than FUdR through a ATB0,+-mediated prodrug approach. The present study provided the first proof-of-concept of exploiting ATB0,+ for tumor-selective delivery of nucleoside analogues in the form of prodrug.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00149?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00149</a>.1H NMR (400 MHz, DMSO-d6), 13C NMR (100 MHz, DMSO-d6), and HPLC of 5′-α-l-Val-FUdR, 3′-α-l-Val-FUdR, 3′,5′-di-α-l-Val-FUdR, 5′-β-l-Asp-FUdR, 3′-β-l-Asp-FUdR, 3′,5′-di-β-l-Asp-FUdR, 5′-γ-l-Glu-FUdR, 3′-γ-l-Glu-FUdR, and 3′,5′-di-γ-l-Glu-FUdR (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00149/suppl_file/jm0c00149_si_001.pdf">PDF</a>)Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00149/suppl_file/jm0c00149_si_002.csv">CSV</a>)Coordinates of homology models for ATB0,+ (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00149/suppl_file/jm0c00149_si_003.pdb">PDB</a>)This article has not yet been cited by other publications.

Two-step Synthesis of Structure-Diverse D-Galactose Conjugates and Polymeric Prodrugs of Floxuridine Via Controllable Regioselective Enzymatic Acylation of 3′- or 5′-OH Group of Floxuridine

Synthesis of Monosaccharide Derivatives and Polymeric Prodrugs of 5-Fluorouridine Via Two-Step Enzymatic or Chemo-Enzymatic Highly Regioselective Strategy

Surface decoration of PLGA nanoparticles enables efficient transport of floxuridine oligomers into mammalian cells

Lipase‐catalyzed Synthesis of Polymeric Prodrugs of Nonsteroidal Anti‐inflammatory Drugs

Regioselective Synthesis of 3′-O-caproyl-floxuridine Catalyzed by Pseudomonas Cepacia Lipase

Bifunctional and Unusual Amino Acid β- or γ-Ester Prodrugs of Nucleoside Analogues for Improved Affinity to ATB 0,+ and Enhanced Metabolic Stability: An Application to Floxuridine

Chemoenzymatic Synthesis, Characterization, and Controlled Release of Functional Polymeric Prodrugs with Acyclovir As Pendant

Late-stage C(sp2)-H and C(sp3)-H Glycosylation of C-aryl/alkyl Glycopeptides: Mechanistic Insights and Fluorescence Labeling.

Esterase-Responsive Floxuridine-Tethered Multifunctional Nanoparticles for Targeted Cancer Therapy

Synthesis of 2‐Amino‐2‐deoxy‐1,3‐dithioidoglycosides via Organocatalytic relay Glycosylation of 3‐O‐acetyl‐2‐Nitrogalactals

Synthesis of C4‐Acyl‐tetrofuranosides and C5‐Acyl‐pentopyranosides Enabled by the Liebeskind‐Srogl Cross‐Coupling Reaction

Novel Designed Polymer–acyclovir Conjugates with Linker‐controlled Drug Release and Hepatoma Cell Targeting

Synthesis and Characterization of Optically Active Macromolecular Prodrugs with Chemo-Enzymatic Protocol

Novel Mutual Pro-Drugs of 2′,3′-Dideoxyinosine with 3-Octadecyloxy-propane-1,2-diol by Straightforward Enzymatic Regioselective Synthesis in Acetone

Optimized 5-Fluorouridine Prodrug for Co-Loading with Doxorubicin in Clinically Relevant Liposomes

Chemo-enzymatic synthesis of optically active polymeric prodrug of naproxen, ketoprofen and ibuprofen

Switching Residues: A Platform for the Synthesis of Fidaxomicin Antibiotics

An acid-activatable fluorouracil prodrug for colorectal cancer synergistic therapy

Two-step Sequential Synthesis of Pyrimidine Derivatives Containing a Sugar Branch Via Combining of Enzymatic Michael Addition/acylation

Synthesis and biological activities of galactose–aspirin conjugate prodrug designed for ADEPT and PMT

Preparation of novel sulfated polysaccharide-carboxymethyl-5-fluorouracil-folic acid conjugates for targeted anticancer drug delivery